PULSAR: phase 2, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of sotatercept (ACE-on) when added to standard of care (SOC) for treatment of pulmonary arterial hypertension (PAH)EUROPEAN RESPIRATORY JOURNALIF212019-11-214PRE
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic PurpuraNEW ENGLAND JOURNAL OF MEDICINEIF78.52019-01-24639OAAI
Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpuraJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52017-07-0199OAAI
Efficacy and safety of sublingual tablets of house dust mite allergen extracts: Results of a dose-ranging study in an environmental exposure chamberJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22016-08-0151OAAI
Immunological Effects of Treatment with STG320 Sublingual Tablets of House Dust Mite Allergen Extracts in Subjects with HDM-Associated Allergic AsthmaJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22016-02-011PREAI
Safety of STG320 Sublingual Tablets of House Dust Mite Allergen Extracts in Subjects with HDMA-ssociated Allergic Rhinitis: Results of a Pooled AnalysisJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22016-02-011OAAI
House Dust Mite-Associated Allergic Rhinitis: Efficacy of STG320 Sublingual Tablets of House Dust Mite Allergen ExtractsJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22016-02-010PREAI
Treatment with STG320 Sublingual Tablets of House Dust Mite Allergen Extracts: Profile of Subjects with HDM-Associated Allergic Rhinitis in the Clinical Development ProgramJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22016-02-010PREAI
High doses of sublingual tablets of house dust mite allergen extracts: Lung function assessment in a phase I study in adults with mite-associated allergic asthmaEUROPEAN RESPIRATORY JOURNALIF212015-10-300PRE
Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cellsALLERGYIF122015-03-2616PREAI
Safety of the 300 IR and 500 IR Doses of a House Dust Mite Allergen Extracts Sublingual Tablet in Adults with Allergic RhinitisJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22015-02-010PREAI
Safety of a Sublingual Tablet of House Dust Mite Allergen Extracts in an Environmental Exposure Chamber StudyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22015-02-011OAAI
Clinical relevance of house dust mite immunotherapy ReplyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22015-01-010OAAI
Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitisJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22014-06-01166PRE
Efficacy Of 300IR 5-Grass Pollen Sublingual Tablets In The Treatment Of Rhinitis Symptoms In Patients With Grass Pollen-Induced Allergic RhinoconjunctivitisJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22014-02-010OA
Efficacy Of 300IR 5-Grass Pollen Sublingual Tablets In Grass Pollen-Induced Allergic Rhinoconjunctivitis: Pooled Analysis By AgeJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22014-02-010PRE
Efficacy Of 300IR 5-Grass Pollen Sublingual Tablets In Grass Pollen-Associated Allergic Rhinoconjunctivitis: Pooled Analysis By Level Of Pollen ExposureJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22014-02-010PRE
Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapyCLINICAL AND EXPERIMENTAL ALLERGYIF5.22013-11-2230PREAI
Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitisCLINICAL AND EXPERIMENTAL ALLERGYIF5.22013-04-2279PREAI
Efficacy of House Dust Mite Sublingual Immunotherapy in Adults with Allergic Rhinitis: Results of an Environmental Exposure Chamber StudyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22013-02-014OA
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向